NIH-funded research R21 grant

Tracking HIV-specific memory cells in the immune system

Official title: Clonal lineage tracing of HIV specific NK memory cells

Funded at Fred Hutchinson Cancer Center · NIH-11183911 · Data updated 2026-11-12

This study is looking at how special immune cells called natural killer (NK) cells remember and fight against HIV in women who have been living with the virus for a long time, to help us learn more about how to improve future vaccines.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionFred Hutchinson Cancer Center
NIH-funded
Lab location1 site (Seattle, United States)
Project startMay 22, 2025
Project endApril 30, 2027
Funding year2025
Award (this year)$220,000
NIH project number1R21AI186724-01A1
Project IDNIH-11183911 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are women who have been infected with HIV and have longitudinal samples available for analysis.

Less likely to help

Patients who are not HIV-infected or do not have access to the required longitudinal samples may not benefit from this research.

What this research studies

This research investigates how certain immune cells, known as natural killer (NK) cells, can remember and respond to HIV infections. By using a novel technique called ASAP-seq, the study aims to trace the lineage of these NK cells in a unique group of HIV-infected women over a 30-year period. The approach involves analyzing samples collected before and after HIV infection to understand how these memory cells develop and persist. This could provide valuable insights into the immune response to HIV and inform future vaccine strategies.

Why it matters

Potential benefit: If successful, this research could enhance our understanding of immune memory against HIV, potentially leading to improved vaccines and therapies.

How similar studies have gone: Previous studies have shown success in tracking immune memory in other viral infections, suggesting that this approach could yield valuable insights for HIV as well.

Where this research is happening

  • Fred Hutchinson Cancer Center
    Seattle, United States
    Active

Researchers

  • Principal investigator: Overbaugh, Julie M. — Fred Hutchinson Cancer Center
  • Study coordinator: Overbaugh, Julie M.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.